<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02309138</url>
  </required_header>
  <id_info>
    <org_study_id>PRO14070556</org_study_id>
    <secondary_id>R01HD079647</secondary_id>
    <nct_id>NCT02309138</nct_id>
  </id_info>
  <brief_title>Comparison of Two Screening Strategies for Gestational Diabetes (GDM2)</brief_title>
  <acronym>GDM2</acronym>
  <official_title>Comparison of Two Screening Strategies for Gestational Diabetes (GDM2)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Esa M Davis, MD MPH FAAFP</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Pittsburgh</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a single site blinded RCT of 920 pregnant women with singleton gestation designed to
      compare the Carpenter-Coustan and IADPSG criteria for diagnosing gestational diabetes.
      Maternal metabolic profiles and infant growth will be assessed at randomization and at one
      year postpartum.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Impaired glucose metabolism (gestational diabetes (GDM) and mild hyperglycemia) that occurs
      during pregnancy is associated with an increased risk for pregnancy complications and is also
      an early indication of long-term metabolic dysfunction leading to diabetes and cardiovascular
      disease. In the US, GDM is diagnosed using a two-step screening and diagnostic approach. The
      International Association of Diabetes and Pregnancy Study Group (IADPSG) proposed a one-step
      diagnostic approach that broadens the definition of GDM by lowering the cutoff values to
      include women with milder forms of hyperglycemia, who would have screened normal under the
      current two-step approach. The goal of these recommendations is better identification of
      women at risk for pregnancy complications and long-term metabolic dysfunction, but it results
      in a significant increase in the prevalence of GDM. The NIH GDM Consensus Development
      Conference committee does not recommend changing from the current two-step
      screening/diagnostic approach to the IADPSG one-step diagnostic approach without trials
      demonstrating that increasing the number of women diagnosed as having GDM results in better
      outcomes. We aim to 1) conduct a &quot;real world&quot; randomized controlled trial (RCT) to determine
      differences in short-term perinatal health outcomes between the two predominant GDM screening
      approaches, and 2) prospectively follow the mothers to examine their metabolic risk profiles
      and the growth of their infants at 1 year postpartum. Based on a pilot study, we propose a
      single site blinded RCT of 920 pregnant women ages 18-45 years without a diagnosis of
      diabetes, with a singleton pregnancy (18-24 wks gestation). Participants will have a
      non-fasting 1 hour 50 gm glucose challenge test (GCT) performed between 24-28 weeks'
      gestation. Women with 50 gm GCT results &lt; 200 mg/dL will be randomized to receive either a
      fasting 2 hour 75 gm oral glucose tolerance test (OGTT) or a 3 hour 100 gm OGTT. GDM will be
      diagnosed using the IADPSG criteria for women receiving the 75 gm OGTT and Carpenter-Coustan
      criteria for women receiving the 100 gm. Participants and their physicians will be informed
      of the diagnosis of GDM, but blinded to the specific test results and diagnostic criteria.
      Participants with GDM will receive treatment from their primary provider. Questionnaires will
      be used to assess participants' and physicians' views on GDM testing. Metabolic profiles will
      be assessed at randomization and at a year postpartum. The primary outcome measure is
      large-for-gestational age fetal growth. The rationale for this RCT is that this is a unique
      opportunity to compare the two methods. At the end of the study, we will know whether women
      diagnosed at lower glucose levels with the IADPSG criteria are more likely to have adverse
      perinatal outcomes. We hypothesize that using IADPSG diagnostic criteria will result in
      greater detection of women with impaired glucose metabolism and treating these women will
      reduce adverse perinatal outcomes and prevent long-term metabolic dysfunction. This study
      will provide level A data for endorsing universal screening guidelines for GDM by major
      organizations and implementation into clinical care.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">August 11, 2015</start_date>
  <completion_date type="Actual">June 5, 2020</completion_date>
  <primary_completion_date type="Actual">July 3, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Screening</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Large for Gestational Age (LGA) Infant</measure>
    <time_frame>at time of delivery</time_frame>
    <description>birth weight equal to or greater than the 90th percentile for gestational age and sex</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Cesarean Delivery</measure>
    <time_frame>at delivery (approximately 40 weeks' gestation)</time_frame>
    <description>the delivery of a baby through a surgical incision in the mother's abdomen and uterus</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Maternal Composite Morbidity</measure>
    <time_frame>at delivery (approximately 40 weeks' gestation)</time_frame>
    <description>maternal pre-eclampsia, 3rd or 4th degree vaginal lacerations, post-partum hemorrhage</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Neonatal Composite Morbidity</measure>
    <time_frame>7 days after birth</time_frame>
    <description>1) hypoglycemia: blood glucose &lt; 40mg/dl); 2) hyperbilirubinemia requiring treatment, clinical jaundice; 3)hyperinsulinemia- measured with c peptide level from venous cord blood; 4) still birth- absence of fetal heart tones before delivery, 5) birth trauma= Shoulder dystocia/brachial plexus injuries.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">921</enrollment>
  <condition>Gestational Diabetes</condition>
  <condition>Pregnancy</condition>
  <condition>Glucose Intolerance</condition>
  <arm_group>
    <arm_group_label>3 hour 100 gm OGTT (CC Criteria)</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Gestational diabetes screening with fasting 3 hour 100 gm. Receive a fasting 3 hour 100 gram oral glucose tolerance test and are diagnosed based on the Carpenter Coustan Criteria: a 50 gm Glucose tolerance test of &gt;130 + fasting 3 hour 100 gram oral glucose tolerance test with two or more values greater than the following diagnostic threshold: Fasting 95, 1-hour 180, 2-hour 155, or 3 hour 140 mg/dL . A positive criteria will be diagnostic for gestational diabetes.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2 hr 75 gm OGTT (IADPSG Criteria)</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Gestational diabetes screening with fasting 2 hour 75g. Receive a fasting 2 hour 75 gm oral glucose tolerance test and diagnosed based on the IADPSG which is if one or more values exceed the following diagnostic threshold: Fasting 92, 1-hour 180, or 2-hour 153 mg/dL.</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Gestational diabetes screening with fasting 3 hour 100 gm</intervention_name>
    <description>Participants receive fasting 3 hour 100 gm oral glucose tolerance test</description>
    <arm_group_label>3 hour 100 gm OGTT (CC Criteria)</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Gestational diabetes screening with fasting 2 hour 75g</intervention_name>
    <description>Participants receive fasting 2 hour 75 gm oral glucose tolerance test</description>
    <arm_group_label>2 hr 75 gm OGTT (IADPSG Criteria)</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Pregnancy between 18-24 weeks of gestation

          -  Singleton gestation

          -  Planning to deliver at Magee-Womens Hospital, Pittsburgh, Pennsylvania

        Exclusion Criteria:

          -  Preexisting type 1 or 2 diabetes

          -  Diabetes diagnosed at less than 24 weeks gestational age (GA)

          -  Multiple gestations ( e.g. twins or triplets)

          -  Hypertension requiring medications

          -  Corticosteroid (IM, oral or IV) use in the 30 days prior to enrollment

          -  Major congenital anomaly with anticipated preterm delivery due to maternal or fetal
             indications &lt; 28 wks GA

          -  Inability to complete the glucose testing before 30 completed weeks GA

          -  Advanced HIV( on medications that cause hyperglycemia), severe liver disease, gastric
             bypass surgery or other illness/surgeries that preclude them from drinking the glucola
             solution.
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>45 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Esa M Davis, MD MPH</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Pittsburgh</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>UPMC- Magee Womens Hospital</name>
      <address>
        <city>Pittsburgh</city>
        <state>Pennsylvania</state>
        <zip>15213</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Abebe KZ, Scifres C, Simhan HN, Day N, Catalano P, Bodnar LM, Costacou T, Matthew D, Illes A, Orris S, Duell J, Ly K, Davis EM. Comparison of Two Screening Strategies for Gestational Diabetes (GDM(2)) Trial: Design and rationale. Contemp Clin Trials. 2017 Nov;62:43-49. doi: 10.1016/j.cct.2017.08.012. Epub 2017 Aug 18.</citation>
    <PMID>28823926</PMID>
  </reference>
  <verification_date>July 2020</verification_date>
  <study_first_submitted>November 25, 2014</study_first_submitted>
  <study_first_submitted_qc>December 2, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 5, 2014</study_first_posted>
  <results_first_submitted>July 2, 2020</results_first_submitted>
  <results_first_submitted_qc>July 2, 2020</results_first_submitted_qc>
  <results_first_posted type="Actual">July 20, 2020</results_first_posted>
  <last_update_submitted>July 2, 2020</last_update_submitted>
  <last_update_submitted_qc>July 2, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">July 20, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>University of Pittsburgh</investigator_affiliation>
    <investigator_full_name>Esa M Davis, MD MPH FAAFP</investigator_full_name>
    <investigator_title>MD</investigator_title>
  </responsible_party>
  <keyword>gestational diabetes screening</keyword>
  <keyword>Carpenter Coustan Criteria</keyword>
  <keyword>IADPSG criteria</keyword>
  <keyword>Large for gestational age birth weight</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diabetes, Gestational</mesh_term>
    <mesh_term>Diabetes Mellitus</mesh_term>
    <mesh_term>Glucose Intolerance</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>Once the study is completed and the investigators have published the main manuscripts regarding the outcomes of the trial. De-identified data will be made available by request, review and approval of the investigators and the institution regulatory committee.</ipd_description>
    <ipd_info_type>Study Protocol</ipd_info_type>
    <ipd_info_type>Statistical Analysis Plan (SAP)</ipd_info_type>
    <ipd_time_frame>Data will be shared in the appropriate time frame required by policy.</ipd_time_frame>
    <ipd_access_criteria>An application and review process will be implemented for accessing data.</ipd_access_criteria>
  </patient_data>
  <provided_document_section>
    <provided_document>
      <document_type>Statistical Analysis Plan</document_type>
      <document_has_protocol>No</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>April 29, 2020</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/38/NCT02309138/SAP_000.pdf</document_url>
    </provided_document>
    <provided_document>
      <document_type>Study Protocol</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>No</document_has_sap>
      <document_date>December 1, 2019</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/38/NCT02309138/Prot_001.pdf</document_url>
    </provided_document>
  </provided_document_section>

  <clinical_results>

    <participant_flow>
      <recruitment_details>Pregnant women were recruited from June 2015 to February 2019 from 10 obstetrical clinics affiliated with Magee Women's Hospital in Pittsburgh,Pennsylvania</recruitment_details>
      <group_list>
        <group group_id="P1">
          <title>3 Hour 100 gm OGTT (CC Criteria)</title>
          <description>Gestational diabetes screening with fasting 3 hour 100 gm. Receive a fasting 3 hour 100 gram oral glucose tolerance test and are diagnosed based on the Carpenter Coustan Criteria: a 50 gm Glucose tolerance test of &gt;130 + fasting 3 hour 100 gram oral glucose tolerance test with two or more values greater than the following diagnostic threshold: Fasting 95, 1-hour 180, 2-hour 155, or 3 hour 140 mg/dL . A positive criteria will be diagnostic for gestational diabetes.
Gestational diabetes screening with fasting 3 hour 100 gm: Participants receive fasting 3 hour 100 gm oral glucose tolerance test</description>
        </group>
        <group group_id="P2">
          <title>2 hr 75 gm OGTT (IADPSG Criteria)</title>
          <description>Gestational diabetes screening with fasting 2 hour 75g. Receive a fasting 2 hour 75 gm oral glucose tolerance test and diagnosed based on the International Association of the Diabetes in Pregnancy Study Group (IADPSG) which is if one or more values exceed the following diagnostic threshold: Fasting 92, 1-hour 180, or 2-hour 153 mg/dL.
Gestational diabetes screening with fasting 2 hour 75g: Participants receive fasting 2 hour 75 gm oral glucose tolerance test</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="460"/>
                <participants group_id="P2" count="461"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="412"/>
                <participants group_id="P2" count="443"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="48"/>
                <participants group_id="P2" count="18"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Withdrawal by Subject</title>
              <participants_list>
                <participants group_id="P1" count="44"/>
                <participants group_id="P2" count="15"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Protocol Violation</title>
              <participants_list>
                <participants group_id="P1" count="4"/>
                <participants group_id="P2" count="2"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>delivered before visit 2</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="1"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>3 Hour 100 gm OGTT (CC Criteria)</title>
          <description>Gestational diabetes screening with fasting 3 hour 100 gm. Receive a fasting 3 hour 100 gram oral glucose tolerance test and are diagnosed based on the Carpenter Coustan Criteria: a 50 gm Glucose tolerance test of &gt;130 + fasting 3 hour 100 gram oral glucose tolerance test with two or more values greater than the following diagnostic threshold: Fasting 95, 1-hour 180, 2-hour 155, or 3 hour 140 mg/dL . A positive criteria will be diagnostic for gestational diabetes.
Gestational diabetes screening with fasting 3 hour 100 gm: Participants receive fasting 3 hour 100 gm oral glucose tolerance test</description>
        </group>
        <group group_id="B2">
          <title>2 hr 75 gm OGTT (IADPSG Criteria)</title>
          <description>Gestational diabetes screening with fasting 2 hour 75g. Receive a fasting 2 hour 75 gm oral glucose tolerance test and diagnosed based on the IADPSG which is if one or more values exceed the following diagnostic threshold: Fasting 92, 1-hour 180, or 2-hour 153 mg/dL.
Gestational diabetes screening with fasting 2 hour 75g: Participants receive fasting 2 hour 75 gm oral glucose tolerance test</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="460"/>
            <count group_id="B2" value="461"/>
            <count group_id="B3" value="921"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="460"/>
                    <count group_id="B2" value="461"/>
                    <count group_id="B3" value="921"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="28.8" spread="5.1"/>
                    <measurement group_id="B2" value="28.6" spread="5.3"/>
                    <measurement group_id="B3" value="28.7" spread="5.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="460"/>
                    <count group_id="B2" value="461"/>
                    <count group_id="B3" value="921"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="460"/>
                    <measurement group_id="B2" value="461"/>
                    <measurement group_id="B3" value="921"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Ethnicity (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="460"/>
                    <count group_id="B2" value="461"/>
                    <count group_id="B3" value="921"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Hispanic or Latino</title>
                  <measurement_list>
                    <measurement group_id="B1" value="15"/>
                    <measurement group_id="B2" value="15"/>
                    <measurement group_id="B3" value="30"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Not Hispanic or Latino</title>
                  <measurement_list>
                    <measurement group_id="B1" value="443"/>
                    <measurement group_id="B2" value="445"/>
                    <measurement group_id="B3" value="888"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="2"/>
                    <measurement group_id="B2" value="1"/>
                    <measurement group_id="B3" value="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="460"/>
                    <count group_id="B2" value="461"/>
                    <count group_id="B3" value="921"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>American Indian or Alaska Native</title>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="1"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Asian</title>
                  <measurement_list>
                    <measurement group_id="B1" value="9"/>
                    <measurement group_id="B2" value="18"/>
                    <measurement group_id="B3" value="27"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Native Hawaiian or Other Pacific Islander</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="2"/>
                    <measurement group_id="B3" value="2"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Black or African American</title>
                  <measurement_list>
                    <measurement group_id="B1" value="161"/>
                    <measurement group_id="B2" value="139"/>
                    <measurement group_id="B3" value="300"/>
                  </measurement_list>
                </category>
                <category>
                  <title>White</title>
                  <measurement_list>
                    <measurement group_id="B1" value="249"/>
                    <measurement group_id="B2" value="261"/>
                    <measurement group_id="B3" value="510"/>
                  </measurement_list>
                </category>
                <category>
                  <title>More than one race</title>
                  <measurement_list>
                    <measurement group_id="B1" value="26"/>
                    <measurement group_id="B2" value="27"/>
                    <measurement group_id="B3" value="53"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="14"/>
                    <measurement group_id="B2" value="14"/>
                    <measurement group_id="B3" value="28"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>pre-pregnancy BMI</title>
          <population>participant data missing</population>
          <units>kg/m2</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="399"/>
                    <count group_id="B2" value="428"/>
                    <count group_id="B3" value="827"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="26.6" spread="6.8"/>
                    <measurement group_id="B2" value="26.9" spread="7.2"/>
                    <measurement group_id="B3" value="26.8" spread="7.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Glucose Challenge 50 gm test</title>
          <units>mg/dl</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="460"/>
                    <count group_id="B2" value="461"/>
                    <count group_id="B3" value="921"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="104.7" spread="27.7"/>
                    <measurement group_id="B2" value="107.8" spread="28.9"/>
                    <measurement group_id="B3" value="106.2" spread="28.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>previous history of gestational diabetes</title>
          <population>participant missing data</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="399"/>
                    <count group_id="B2" value="429"/>
                    <count group_id="B3" value="828"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="8"/>
                    <measurement group_id="B2" value="14"/>
                    <measurement group_id="B3" value="22"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>First degree family history of diabetes</title>
          <population>participant missing data</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="393"/>
                    <count group_id="B2" value="415"/>
                    <count group_id="B3" value="808"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="97"/>
                    <measurement group_id="B2" value="103"/>
                    <measurement group_id="B3" value="200"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Large for Gestational Age (LGA) Infant</title>
        <description>birth weight equal to or greater than the 90th percentile for gestational age and sex</description>
        <time_frame>at time of delivery</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Overall IADPSG Arm</title>
            <description>Participants randomized into the IADPSG arm</description>
          </group>
          <group group_id="O2">
            <title>Overall Carpenter Coustan</title>
            <description>Participants randomized in the the Carpenter Coustan arm</description>
          </group>
          <group group_id="O3">
            <title>IADPSG With no GDM</title>
            <description>Participants diagnosed as having no GDM by the IADPSG criteria.</description>
          </group>
          <group group_id="O4">
            <title>Carpenter Coustan With no GDM</title>
            <description>Participants diagnosed as having no GDM by the Carpenter Coustan criteria</description>
          </group>
        </group_list>
        <measure>
          <title>Large for Gestational Age (LGA) Infant</title>
          <description>birth weight equal to or greater than the 90th percentile for gestational age and sex</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="443"/>
                <count group_id="O2" value="412"/>
                <count group_id="O3" value="364"/>
                <count group_id="O4" value="377"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="34"/>
                    <measurement group_id="O2" value="35"/>
                    <measurement group_id="O3" value="28"/>
                    <measurement group_id="O4" value="34"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Co-primary hypotheses #1: women diagnosed using the IADPSG criteria will have lower rates of large-for-gestational age infants compared to those diagnosed using the Carpenter-Coustan criteria.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.668</p_value>
            <p_value_desc>Each co-primary hypothesis was tested at the 2.5% significance level.</p_value_desc>
            <method>Regression, Logistic</method>
            <method_desc>In the ITT, logistic regression was used to quantify the probability of large-for-gestational age as a function of the study arm and clinic type.</method_desc>
            <param_type>Risk Ratio (RR)</param_type>
            <param_value>0.903</param_value>
            <ci_percent>97.5</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.538</ci_lower_limit>
            <ci_upper_limit>1.516</ci_upper_limit>
            <estimate_desc>A relative risk &lt; 1 represents a benefit in the direction of the IADPSG group, while a value &gt; 1 represents a benefit towards the CC group.</estimate_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O3</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Co-primary hypothesis #2: women classified as “no gestational diabetes” by the IADPSG criteria will have lower rates of large-for-gestational age infants compared to those classified in the Carpenter-Coustan criteria.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.853</p_value>
            <p_value_desc>Each co-primary hypothesis was tested at the 2.5% significance level.</p_value_desc>
            <method>Regression, Logistic</method>
            <method_desc>In the ITT, logistic regression was used to quantify the probability of large-for-gestational age as a function of the study arm and clinic type.</method_desc>
            <param_type>Risk Ratio (RR)</param_type>
            <param_value>0.853</param_value>
            <ci_percent>97.5</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.493</ci_lower_limit>
            <ci_upper_limit>1.475</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Cesarean Delivery</title>
        <description>the delivery of a baby through a surgical incision in the mother's abdomen and uterus</description>
        <time_frame>at delivery (approximately 40 weeks' gestation)</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Overall IADPSG Arm</title>
            <description>Participants randomized into the IADPSG arm</description>
          </group>
          <group group_id="O2">
            <title>Overall Carpentar-Coustan Arm</title>
            <description>Participants randomized in the the Carpenter Coustan arm</description>
          </group>
          <group group_id="O3">
            <title>IADPSG Criteria w/ No GDM</title>
            <description>Participants randomized in the the IADPSG arm w &quot;No GDM&quot; classification</description>
          </group>
          <group group_id="O4">
            <title>CC Criteria w/ No GDM</title>
            <description>Participants randomized in the the Carpenter Coustan arm w/ &quot;No GDM&quot; classification</description>
          </group>
        </group_list>
        <measure>
          <title>Cesarean Delivery</title>
          <description>the delivery of a baby through a surgical incision in the mother's abdomen and uterus</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="449"/>
                <count group_id="O2" value="423"/>
                <count group_id="O3" value="365"/>
                <count group_id="O4" value="377"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="131"/>
                    <measurement group_id="O2" value="118"/>
                    <measurement group_id="O3" value="101"/>
                    <measurement group_id="O4" value="101"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.6669</p_value>
            <method>Regression, Logistic</method>
            <param_type>Risk Ratio (RR)</param_type>
            <param_value>1.046</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.847</ci_lower_limit>
            <ci_upper_limit>1.291</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O3</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.8394</p_value>
            <method>Regression, Logistic</method>
            <param_type>Risk Ratio (RR)</param_type>
            <param_value>1.033</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.816</ci_lower_limit>
            <ci_upper_limit>1.307</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Maternal Composite Morbidity</title>
        <description>maternal pre-eclampsia, 3rd or 4th degree vaginal lacerations, post-partum hemorrhage</description>
        <time_frame>at delivery (approximately 40 weeks' gestation)</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Overall IADPSG Arm</title>
            <description>Participants randomized into the IADPSG arm</description>
          </group>
          <group group_id="O2">
            <title>Overall Carpenter Coustan</title>
            <description>Participants randomized in the the Carpenter Coustan arm</description>
          </group>
          <group group_id="O3">
            <title>IADPSG With no GDM</title>
            <description>Participants diagnosed as having no GDM by the IADPSG criteria.</description>
          </group>
          <group group_id="O4">
            <title>Carpenter Coustan With no GDM</title>
            <description>Participants diagnosed as having no GDM by the CC criteria</description>
          </group>
        </group_list>
        <measure>
          <title>Maternal Composite Morbidity</title>
          <description>maternal pre-eclampsia, 3rd or 4th degree vaginal lacerations, post-partum hemorrhage</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="442"/>
                <count group_id="O2" value="425"/>
                <count group_id="O3" value="365"/>
                <count group_id="O4" value="379"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="77"/>
                    <measurement group_id="O2" value="75"/>
                    <measurement group_id="O3" value="62"/>
                    <measurement group_id="O4" value="63"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.9335</p_value>
            <method>Regression, Logistic</method>
            <param_type>Risk Ratio (RR)</param_type>
            <param_value>0.987</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.740</ci_lower_limit>
            <ci_upper_limit>1.318</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O3</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.9260</p_value>
            <method>Regression, Logistic</method>
            <param_type>Risk Ratio (RR)</param_type>
            <param_value>1.022</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.742</ci_lower_limit>
            <ci_upper_limit>1.407</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Neonatal Composite Morbidity</title>
        <description>1) hypoglycemia: blood glucose &lt; 40mg/dl); 2) hyperbilirubinemia requiring treatment, clinical jaundice; 3)hyperinsulinemia- measured with c peptide level from venous cord blood; 4) still birth- absence of fetal heart tones before delivery, 5) birth trauma= Shoulder dystocia/brachial plexus injuries.</description>
        <time_frame>7 days after birth</time_frame>
        <group_list>
          <group group_id="O1">
            <title>2 hr 75 gm OGTT (IADPSG Criteria)</title>
            <description>Gestational diabetes screening with fasting 2 hour 75g. Receive a fasting 2 hour 75 gm oral glucose tolerance test and diagnosed based on the IADPSG which is if one or more values exceed the following diagnostic threshold: Fasting 92, 1-hour 180, or 2-hour 153 mg/dL.
Gestational diabetes screening with fasting 2 hour 75g: Participants receive fasting 2 hour 75 gm oral glucose tolerance test</description>
          </group>
          <group group_id="O2">
            <title>3 Hour 100 gm OGTT (CC Criteria)</title>
            <description>Gestational diabetes screening with fasting 3 hour 100 gm. Receive a fasting 3 hour 100 gram oral glucose tolerance test and are diagnosed based on the Carpenter Coustan Criteria: a 50 gm Glucose tolerance test of &gt;130 + fasting 3 hour 100 gram oral glucose tolerance test with two or more values greater than the following diagnostic threshold: Fasting 95, 1-hour 180, 2-hour 155, or 3 hour 140 mg/dL . A positive criteria will be diagnostic for gestational diabetes.
Gestational diabetes screening with fasting 3 hour 100 gm: Participants receive fasting 3 hour 100 gm oral glucose tolerance test</description>
          </group>
          <group group_id="O3">
            <title>IADPSG Without GDM</title>
            <description>Participants diagnosed as having no GDM by IADPSG criteria</description>
          </group>
          <group group_id="O4">
            <title>Carpenter Coustan Without GDM</title>
            <description>Participants diagnosed as having no GDM with the Carpenter Coustan criteria</description>
          </group>
        </group_list>
        <measure>
          <title>Neonatal Composite Morbidity</title>
          <description>1) hypoglycemia: blood glucose &lt; 40mg/dl); 2) hyperbilirubinemia requiring treatment, clinical jaundice; 3)hyperinsulinemia- measured with c peptide level from venous cord blood; 4) still birth- absence of fetal heart tones before delivery, 5) birth trauma= Shoulder dystocia/brachial plexus injuries.</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="442"/>
                <count group_id="O2" value="425"/>
                <count group_id="O3" value="365"/>
                <count group_id="O4" value="379"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="83"/>
                    <measurement group_id="O2" value="57"/>
                    <measurement group_id="O3" value="57"/>
                    <measurement group_id="O4" value="48"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.0322</p_value>
            <method>Regression, Logistic</method>
            <param_type>Risk Ratio (RR)</param_type>
            <param_value>1.400</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>1.027</ci_lower_limit>
            <ci_upper_limit>1.909</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O3</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.2643</p_value>
            <method>Regression, Logistic</method>
            <param_type>Risk Ratio (RR)</param_type>
            <param_value>1.233</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.864</ci_lower_limit>
            <ci_upper_limit>1.760</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>Adverse events timeframe in which data were collected was from the time of enrollment of the first participants to the final participant 12 month F/U (~ 5 years). However, adverse event data on each participants was collected within 48 hours of the requirement to fast prior to lab work done for the study and any serious adverse events were collected between study visit 1 and 2 and visit 2and delivery, and determined if related to the study procedures.</time_frame>
      <group_list>
        <group group_id="E1">
          <title>3 Hour 100 gm OGTT (CC Criteria)</title>
          <description>Gestational diabetes screening with fasting 3 hour 100 gm. Receive a fasting 3 hour 100 gram oral glucose tolerance test and are diagnosed based on the Carpenter Coustan Criteria: a 50 gm Glucose tolerance test of &gt;130 + fasting 3 hour 100 gram oral glucose tolerance test with two or more values greater than the following diagnostic threshold: Fasting 95, 1-hour 180, 2-hour 155, or 3 hour 140 mg/dL . A positive criteria will be diagnostic for gestational diabetes.
Gestational diabetes screening with fasting 3 hour 100 gm: Participants receive fasting 3 hour 100 gm oral glucose tolerance test</description>
        </group>
        <group group_id="E2">
          <title>2 hr 75 gm OGTT (IADPSG Criteria)</title>
          <description>Gestational diabetes screening with fasting 2 hour 75g. Receive a fasting 2 hour 75 gm oral glucose tolerance test and diagnosed based on the IADPSG which is if one or more values exceed the following diagnostic threshold: Fasting 92, 1-hour 180, or 2-hour 153 mg/dL.
Gestational diabetes screening with fasting 2 hour 75g: Participants receive fasting 2 hour 75 gm oral glucose tolerance test</description>
        </group>
      </group_list>
      <serious_events>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="460"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="461"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="17" subjects_at_risk="460"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="461"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Metabolism and nutrition disorders</title>
            <event_list>
              <event>
                <sub_title>Hypoglycemia</sub_title>
                <description>&lt; 40-30 mg/dl; &lt;2.2-1.7 mol/L</description>
                <counts group_id="E1" events="12" subjects_affected="12" subjects_at_risk="460"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="461"/>
              </event>
              <event>
                <sub_title>Hypoglycemia</sub_title>
                <description>&lt; 30 mg/dl; &lt;1.7 mol/L, life threatening consequences; seizures</description>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="460"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="461"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Nervous system disorders</title>
            <event_list>
              <event>
                <sub_title>migraine headache</sub_title>
                <description>went to Emergency room and as tx and released.</description>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="460"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="461"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Pregnancy, puerperium and perinatal conditions</title>
            <event_list>
              <event>
                <sub_title>heavy vaginal bleeding</sub_title>
                <description>Admitted to hospital with vaginal bleeding due to placenta previa</description>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="460"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="461"/>
              </event>
              <event>
                <sub_title>Premature rupture of membranes</sub_title>
                <description>Pt had spontaneous premature rupture of members right during study visit</description>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="460"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="461"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="154" subjects_at_risk="460"/>
                <counts group_id="E2" subjects_affected="56" subjects_at_risk="461"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Gastrointestinal disorders</title>
            <event_list>
              <event>
                <sub_title>vomiting</sub_title>
                <counts group_id="E1" events="30" subjects_affected="28" subjects_at_risk="460"/>
                <counts group_id="E2" events="12" subjects_affected="12" subjects_at_risk="461"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>General disorders</title>
            <event_list>
              <event>
                <sub_title>Malaise</sub_title>
                <counts group_id="E1" events="8" subjects_affected="8" subjects_at_risk="460"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="461"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Metabolism and nutrition disorders</title>
            <event_list>
              <event>
                <sub_title>nausea</sub_title>
                <counts group_id="E1" events="58" subjects_affected="58" subjects_at_risk="460"/>
                <counts group_id="E2" events="20" subjects_affected="20" subjects_at_risk="461"/>
              </event>
              <event>
                <sub_title>Hypoglycemia</sub_title>
                <counts group_id="E1" events="72" subjects_affected="70" subjects_at_risk="460"/>
                <counts group_id="E2" events="21" subjects_affected="19" subjects_at_risk="461"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Nervous system disorders</title>
            <event_list>
              <event>
                <sub_title>dizziness</sub_title>
                <counts group_id="E1" events="23" subjects_affected="22" subjects_at_risk="460"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="461"/>
              </event>
              <event>
                <sub_title>Headache</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="460"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="461"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Pregnancy, puerperium and perinatal conditions</title>
            <event_list>
              <event>
                <sub_title>Other</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="460"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="461"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Director of Center for Research on Health Care Data Center</name_or_title>
      <organization>University of Pittsburgh</organization>
      <phone>412-692-2023</phone>
      <email>dcenter@pitt.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

